Recent posts

TypePostAuthorRepliesLast updated
PageAndrew S. Goldman, Counsel, Policy and Legal Affairs Claire Cassedy02 days 1 hour ago
Blog entryHarvoni & Sovaldi, Xtandi in Top 20 Costliest Medicare Drugs Zack Struver01 week 5 days ago
Blog entry2016: KEI/MSF comments to NIH on licensing of patents on Attenuated Respiratory Syncytial Virus (RSV) Vaccines James Love02 weeks 6 days ago
Blog entryBloomberg: CVS Will Exclude Xtandi From Formulary in 2017 Zack Struver03 weeks 22 hours ago
Blog entryVivendi-SFR lobbyist nominated to WIPO Staff03 weeks 1 day ago
Blog entryProposal for a WTO Agreement on the Supply of Public goods KEI Staff03 weeks 5 days ago
Blog entrySCP24:WIPO patent committee adopts robust work program on patents and health, limitations and exceptions and quality of patents thiru03 weeks 6 days ago
Blog entryLetter from 56 non-profits and experts to Secretary of State John Kerry on pressure on global access to medicines initiatives Zack Struver04 weeks 32 min ago
Blog entryWIPO GA 2013 to decide on future of the Intergovernmental Committee on Genetic Resources, Traditional Knowledge and Folklore thiru04 weeks 49 min ago
Blog entryHuman Rights Council adopts watershed resolution on Access to Medicines thiru05 weeks 2 days ago
Blog entryRoger Bate: Eclectic booster of corporate views thiru05 weeks 5 days ago
Blog entrySeptember 2004: TACD's Future of WIPO Conference thiru05 weeks 6 days ago
Blog entryFrancis Gurry appoints Sylvie Forbin, lobbyist for Vivendi, as new head of copyright at WIPO James Love05 weeks 6 days ago
Page2016: KEI comments on NIH proposal for exclusive licenses to Chimeron Bio Corporation Diane Singhroy06 weeks 22 hours ago
Blog entryGates Foundation v. Teachscape: Restrictions on Patenting of Gates-Funded Inventions Andrew Goldman06 weeks 22 hours ago
Blog entrySCP 24 - A fruitful discussion? Staff06 weeks 6 days ago
Blog entryWIPO Marrakesh Treaty for the blind to come into force September 30, 2016, following ratification by Canada James Love06 weeks 6 days ago
Book pageKEI Achievements Staff07 weeks 23 hours ago
Blog entrySCP24: African Group submits revised proposal for a WIPO work program on Patents and Health thiru07 weeks 3 days ago
Blog entrySCP24: KEI statement on Patents and Health thiru08 weeks 3 hours ago
PageBackground FAQ on Glivec (imatinib) compulsory license in Colombia Zack Struver08 weeks 3 hours ago
Blog entryApril 28, 2016 letter regarding US Senate Finance threats over compulsory license on Novartis cancer drug patents KEI Staff08 weeks 3 hours ago
PageWIPO SCCR 32 - links to KEI's reports from the meeting Manon Ress08 weeks 3 hours ago
PageNews reports on Senator Hatch pressure over Colombia compulsory license on Novartis drug James Love08 weeks 3 hours ago
Blog entryBriefing Call on National Institutes of Health (NIH) patent policies, 29 June 2016, 11:00 A.M. (EST) Zack Struver08 weeks 4 hours ago